Noninvasive biomarkers as surrogate predictors of clinical and endoscopic remission after infliximab induction in patients with refractory ulcerative colitis

BACKGROUND/AIMS: Treatment of refractory ulcerative colitis (UC) is a clinical challenge, and after biological therapy, monitoring clinical and endoscopic responses is fundamental. We aimed to investigate and compare the predictive power of different noninvasive parameters for clinical remission and...

Descripción completa

Detalles Bibliográficos
Autores principales: Hassan, Elham A., Ramadan, Haidi K., Ismael, Ali A., Mohamed, Khaled F., El-Attar, Madiha M., Alhelali, Ihab
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5539678/
https://www.ncbi.nlm.nih.gov/pubmed/28721978
http://dx.doi.org/10.4103/sjg.SJG_599_16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5539678/
https://www.ncbi.nlm.nih.gov/pubmed/28721978
http://dx.doi.org/10.4103/sjg.SJG_599_16

Ejemplares similares